Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've reached 15mg of Mounjaro, or you're about to. At this maintenance dose — the highest in the licensed UK schedule — side effects are broadly the same types as those at lower doses, but some people notice them more intensely during the first few weeks. The NHS medicines page for tirzepatide confirms that gastrointestinal effects are the most common across all doses, and that they usually settle with time. These are prescription-only medicines; a clinician assesses your suitability and monitors you throughout treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who reach 15mg have already spent several months on Mounjaro. They know what nausea feels like on this treatment, they've found the foods that sit comfortably, and they've worked out that eating slowly matters more than it used to. The step to 15mg can still catch people off guard, though. The dose is nearly six times the 2.5mg starter, and even a well-adjusted digestive system can take time to recalibrate.
Nausea is the effect people mention most. For some it arrives on the day of injection, fades by the next morning, and is barely noticeable after two or three weeks. For others it lingers longer, particularly after larger meals. Loose stools and constipation can alternate in the same person over the same month. Indigestion, a feeling of fullness arriving very quickly, and reflux are also common. Fatigue and mild headache sometimes accompany the first few injections at a new dose. Injection-site redness or itching at the abdomen, thigh or upper arm is possible but usually brief.
These effects are documented across the SURMOUNT clinical programme, the same trial evidence that underpins the NICE recommendation for tirzepatide (TA1026). They are not signs that something has gone wrong. They are signs that the medicine is active. That distinction matters when you're a week into your first 15mg pen and wondering whether to press on.
If you ordered this month and the pen arrived on a Monday, you'll likely have your first post-step injection on a day when you can rest if needed. Planning around your week (including busy periods or travel) is worth a conversation with your prescriber in advance. The Mounjaro overview page has more on how the titration schedule works from the start.
Most side effects at 15mg are uncomfortable rather than dangerous. A handful are not. Knowing the difference is the practical safety information that matters most at this dose.
Severe, persistent stomach pain that spreads into the back (with or without vomiting) is not a typical GI side effect. It can be a sign of acute pancreatitis. The MHRA issued a Drug Safety Update in January 2026 specifically flagging this risk for GLP-1 receptor agonist medicines, including tirzepatide. If this happens, stop injecting and go to A&E or call 999. Do not wait to see if it settles.
Gallbladder symptoms (severe pain in the upper right abdomen, fever, jaundice) also require same-day medical assessment. Rapid weight loss at therapeutic doses can increase the risk of gallstones, so this is not merely a theoretical concern at 15mg.
Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat) are rare but require emergency care immediately.
Dehydration from prolonged vomiting or diarrhoea can strain the kidneys. If you cannot keep fluids down for more than 24 hours, contact your prescriber or GP. You can also reach our support team seven days a week if you have questions about what you're experiencing.
Any suspected side effect (serious or minor) can be logged at the Yellow Card scheme. Your report contributes to the ongoing safety monitoring that keeps the evidence base current for everyone using these medicines.
There are practical things that genuinely help. Smaller meals work better at 15mg than at lower doses for most people, the medicine slows gastric emptying noticeably, and a large plate can feel uncomfortable hours later rather than immediately. Protein at every meal helps maintain muscle while appetite is reduced. Staying hydrated is harder when food feels unappealing; plain water, diluted squash and broths all count.
Some people find that changing the day of their weekly injection shifts any nausea away from days that matter most to them, a Friday injection rather than a Monday one, for instance. That's a practical conversation to have with your prescriber; don't adjust the schedule without checking first.
Constipation at 15mg responds well to dietary fibre, movement and adequate fluids. If it becomes significant, your prescriber can advise. Loose stools often improve once the dose settles; if they persist beyond three to four weeks, raise it. Keeping a brief note of what you experience each week makes that conversation much easier.
People sometimes ask whether side effects at 15mg mean the dose is too high. Sometimes, yes, and staying at a lower dose that you tolerate well is a legitimate clinical decision. If you're on 10mg and wondering how the jump tends to feel, the 10mg Mounjaro side effects page covers what that step typically involves. The right dose for you is whatever your prescriber determines is both effective and tolerable, not necessarily the highest available.
Side effects that are new, worsening after the first three weeks, or significantly affecting your daily life are worth discussing. Your prescriber may suggest slowing the titration, staying at 15mg for longer before any further review, or adjusting how and when you inject. It can also help to look back at how earlier doses felt; our pages covering the side effects of Mounjaro 2.5 and the side effects that commonly arise at the 7.5mg stage are useful reference points for understanding how your response has changed over the titration. You may also find it helpful to review what is recorded about the side effects people typically notice when moving through the 5mg dose, particularly if your notes from earlier in treatment are incomplete.
For people using oral contraceptives, there is a specific point worth raising: tirzepatide can slow the absorption of oral medicines, including the pill. UK guidance recommends adding a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, including the step to 15mg. This applies to this dose in particular, since it is a dose change. Your prescriber should have covered this, but if they haven't, ask.
The general FAQs page covers several questions our prescribers hear regularly about managing Mounjaro. If you're considering treatment and want to understand suitability before starting, the broader weight-loss treatment options page gives a full picture of what's available. And if cost is part of your thinking, the Mounjaro cost context page explains what the current private market looks like without the promotional spin.
Our prescribers discuss side effects as part of every consultation (including repeat reviews) because tolerability shapes the clinical decision at every dose. Speak to our prescribers if you'd like a clinical assessment or have questions about whether 15mg is the right step for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.